Roche Partners With Gilead in Covid Trial of Drug Combination
A box of tablets manufactured by Roche Holding AG in London, U.K. (Photographer: Chris Ratcliffe/Bloomberg)

Roche Partners With Gilead in Covid Trial of Drug Combination

Bookmark
(Bloomberg) -- Roche Holding AG and Gilead Sciences Inc. are initiating a late-stage trial of a two-drug combination in hopes of creating a new weapon in the battle against Covid-19.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.